Background and aim Etiopathogeneses of chronic rhinosinusitis are poorly understood. Recent research emphasizes culture-independent molecular sequencing to identify clusters of flora that may function as drivers of inflammation. Studies also indicate that macrolides are as effective as corticosteroids in controlling chronic rhinosinusitis. In this study, we aimed to isolate microbial cultures from the middle meatus of patients suffering from chronic rhinosinusitis and assess the isolates for similarities and antibiotic sensitivity. We also sought to identify the pathogenic species disrupting the nasal microbiome and provide appropriate antibiotics based on the least minimum inhibitory concentration (MIC) from the cultures. Disease progression and response to treatment were evaluated using the Sino-Nasal Outcome Test-22 (SNOT-22) and the Lund-Kennedy endoscopy scoring system. Specifically, diagnostic nasal endoscopy (DNE) was performed in patients with chronic rhinosinusitis without nasal polyps (CRSnNP), and the pre-treatment Lund-Kennedy score was recorded, along with subjective data collected from the SNOT-22 questionnaire. After isolating cultures from the middle meatus, antibiotic treatment was provided based on these findings. A repeat DNE was conducted to calculate the post-treatment Lund-Kennedy score and collect the post-treatment SNOT-22 score. Finally, the pre- and post-treatment scores were compared to assess any statistically significant differences. Methods The patients upon arrival to the hospital and diagnosed with chronic rhinosinusitis without nasal polyposis (CRSnNP) based on the joint EPOS 2020 Criterion for the same were enrolled in the study. The patients were administered an SNOT-22 Questionnaire for subjective evaluation. The patients underwent a diagnostic nasal endoscopy (DNE) to calculate the Lund-Kennedy score, take swabs from the middle meatus for culture and sensitivity, and provide objective evaluation by the assessing physicians. The scores were recorded at the first visit and on each visit till the two weeks of antibiotic treatment were completed. The patients were treated with antibiotics as per the cultured isolates. The Lund-Kennedy scores and SNOT-22 scores before and after treatment were compared to note the response to treatment. Results The mean average Lund-Kennedy score and SNOT-22 scores dropped following a course of antibiotics. The patients also experienced symptomatic relief. The most commonly isolated organism among the samples evaluated was . The best response to antibiotics was noted with aminoglycosides. Total resistance (100%) to macrolides and amoxicillin was also observed, which contradicts the antibiotic guidelines of EPOS 2020, ICAR 2021, and JTFPP 2014. Conclusion This study found that the invasive species disrupting the local nasal microbiome of the participants consisted of various pathogenic microorganisms. It indicated that a culture-based treatment of CRSnNP will yield better results compared to empirical antibiotics. The present study also suggests revising guidelines for antibiotic use and developing personalized antibiograms for treating chronic rhinosinusitis.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11743748 | PMC |
http://dx.doi.org/10.7759/cureus.76048 | DOI Listing |
Cureus
December 2024
Department of Otolaryngology, Head and Neck Surgery, Sri Devaraj Urs Academy of Higher Education and Research, Kolar, IND.
Background and aim Etiopathogeneses of chronic rhinosinusitis are poorly understood. Recent research emphasizes culture-independent molecular sequencing to identify clusters of flora that may function as drivers of inflammation. Studies also indicate that macrolides are as effective as corticosteroids in controlling chronic rhinosinusitis.
View Article and Find Full Text PDFMedicine (Baltimore)
January 2025
The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha, Hunan Province, China.
Allergic rhinitis (AR) is a common allergic inflammatory disease that affects the upper respiratory tract. Although previous research suggests a potential association between gut microbiota alterations and AR, the causal relationship remains unclear. This study employs Mendelian randomization (MR) to reduce confounding factors and reverse causality.
View Article and Find Full Text PDFRhinology
January 2025
Kuopio, Finland.
Chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and non-steroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD) frequently coexist, forming a complex multimorbid condition often referred to as "global airway disease." This concept reflects shared pathophysiological mechanisms of eosinophilic inflammation and underscores the need for integrated treatment strategies targeting both upper and lower airway manifestations (1). The burden of severe CRSwNP, asthma, and N-ERD is substantial, particularly in terms of reduced quality of life, recurrent exacerbations, revision endoscopic sinus surgeries (ESS), and healthcare utilization (2).
View Article and Find Full Text PDFFront Mol Biosci
January 2025
Department of Otolaryngology Head and Neck Surgery, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
Introduction: Extensive efforts have been made to explore members of the IL-10 family as potential therapeutic strategies for various diseases; however, their biological role in chronic rhinosinusitis with nasal polyps (CRSwNP) remains underexplored.
Methods: Gene expression datasets GSE136825, GSE179265, and GSE196169 were retrieved from the Gene Expression Omnibus (GEO) for analysis. Candidate genes were identified by intersecting differentially expressed genes (DEGs) between the CRSwNP and control groups (DEGsall) with those between the high- and low-score groups within the CRSwNP cohort (DEGsNP).
World Allergy Organ J
January 2025
Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Background: This study aimed to evaluate the impact of severe asthma (SA) treatments after 12 months in achieving clinical remission (CR) within the context of the Severe Asthma Network in Italy (SANI) using the recent SANI definition of CR on treatment.
Methods: CR has been defined by SANI as complete, partial, and no CR. Complete CR is defined by the absence of oral corticosteroids (OCS), no symptoms, no exacerbations, and stable lung function, and partial CR requires the absence of OCS and the fulfillment of 2 out of the other 3 criteria.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!